Imidazole propionate is a driver and therapeutic target in atherosclerosis

Journal:
Nature
Published:
Affiliations:
29
Authors:
39
Institutions Authors Share
Institute of Health Carlos III (ISCIII), Spain
15.750000
15.750000
0.40
Sahlgrenska Academy, GU, Sweden
4.250000
0.11
Autonomous University of Madrid (UAM), Spain
2.916667
0.07
Biomedical Research Networking Centers (CIBER), Spain
2.750000
0.07
San Pablo CEU University (USPCEU), Spain
2.000000
0.05
National and Kapodistrian University of Athens (UOA), Greece
1.333333
0.03
Michigan Medicine, U-M, United States of America (USA)
1.333333
0.03
Sahlgrenska University Hospital (SU), GU, Sweden
1.250000
0.03
Inmunotek, Spain
1.000000
0.03
Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM), Spain
0.666667
0.02
Hospital La Paz Institute for Health Research (IdiPAZ), Spain
0.666667
0.02
Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IP), Spain
0.583333
0.01
Complutense University of Madrid (UCM), Spain
0.500000
0.01
University Medical Centre Mannheim (UMM) at Medical Faculty Mannheim, Uni Heidelberg, Germany
0.500000
0.01
Technical University of Denmark (DTU), Denmark
0.500000
0.01
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)
0.500000
0.01
Mount Sinai Heart, United States of America (USA)
0.333333
0.01
King's College London (KCL), United Kingdom (UK)
0.333333
0.01
University of Patras, Greece
0.333333
0.01
University of Michigan Rogel Cancer Center, United States of America (USA)
0.333333
0.01
The University of Osaka (UOsaka), Japan
0.333333
0.01
Hospital Universitario Fundación Jiménez Díaz (FJD), UAM, Spain
0.333333
0.01
DZHK Partner Site Heidelberg/Mannheim, Germany
0.250000
0.01
Helmholtz Institute for Translational AngioCardioScience (HI-TAC), Germany
0.250000
0.01